Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial.

Details

Serval ID
serval:BIB_BB2B4C6BA5CB
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial.
Journal
Lancet
Author(s)
Righini M., Le Gal G., Aujesky D., Roy P.M., Sanchez O., Verschuren F., Rutschmann O., Nonent M., Cornuz J., Thys F., Le Manach C.P., Revel M.P., Poletti P.A., Meyer G., Mottier D., Perneger T., Bounameaux H., Perrier A.
ISSN
1474-547X
Publication state
Published
Issued date
2008
Peer-reviewed
Oui
Volume
371
Number
9621
Pages
1343-1352
Language
english
Abstract
BACKGROUND: Multislice CT (MSCT) combined with D-dimer measurement can safely exclude pulmonary embolism in patients with a low or intermediate clinical probability of this disease. We compared this combination with a strategy in which both a negative venous ultrasonography of the leg and MSCT were needed to exclude pulmonary embolism. METHODS: We included 1819 consecutive outpatients with clinically suspected pulmonary embolism in a multicentre non-inferiority randomised controlled trial comparing two strategies: clinical probability assessment and either D-dimer measurement and MSCT (DD-CT strategy [n=903]) or D-dimer measurement, venous compression ultrasonography of the leg, and MSCT (DD-US-CT strategy [n=916]). Randomisation was by computer-generated blocks with stratification according to centre. Patients with a high clinical probability according to the revised Geneva score and a negative work-up for pulmonary embolism were further investigated in both groups. The primary outcome was the 3-month thromboembolic risk in patients who were left untreated on the basis of the exclusion of pulmonary embolism by diagnostic strategy. Clinicians assessing outcome were blinded to group assignment. Analysis was per protocol. This study is registered with ClinicalTrials.gov, number NCT00117169. FINDINGS: The prevalence of pulmonary embolism was 20.6% in both groups (189 cases in DD-US-CT group and 186 in DD-CT group). We analysed 855 patients in the DD-US-CT group and 838 in the DD-CT group per protocol. The 3-month thromboembolic risk was 0.3% (95% CI 0.1-1.1) in the DD-US-CT group and 0.3% (0.1-1.2) in the DD-CT group (difference 0.0% [-0.9 to 0.8]). In the DD-US-CT group, ultrasonography showed a deep-venous thrombosis in 53 (9% [7-12]) of 574 patients, and thus MSCT was not undertaken. INTERPRETATION: The strategy combining D-dimer and MSCT is as safe as the strategy using D-dimer followed by venous compression ultrasonography of the leg and MSCT for exclusion of pulmonary embolism. An ultrasound could be of use in patients with a contraindication to CT.
Keywords
Enzyme-Linked Immunosorbent Assay, Female, Fibrin Fibrinogen Degradation Products, Humans, Male, Middle Aged, Probability, Pulmonary Embolism, Risk Factors, Tomography, X-Ray Computed, Venous Thrombosis
Pubmed
Web of science
Create date
27/03/2009 15:59
Last modification date
20/08/2019 15:29
Usage data